A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

NCT01176240 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Orthostatic Hypotension
Parkinson's Disease

Interventions

DRUG: Droxidopa
OTHER: Placebo

Sponsor

Chelsea Therapeutics